You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3101 to 3125 of about 5901
Next 25
01/12/2010
Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol.
01/11/2010
The Kelly Heinz-Grundner Brain Tumor Foundation 2nd Annual Beef & Beer Winter Fundraiser (Delaware!)
01/10/2010
Small Addition to Cancer Drug May Make Big Difference
01/07/2010
Going back to `a chicken in every pot` (Fundraiser for Musella Foundation)
01/06/2010
End of year research grants awarded!
Arlene I. Glasser, 62
DJ and Aspiring Filmmaker O’Sullivan Dies of Brain Tumor
Imetelstat assisted brain and prostate cancer study
01/04/2010
FIRST ANNUAL CLAMBAKE FOR A CURE CELEBRITY CHEF CLAMBAKE COMPETITION
12/23/2009
Brain Cancer: Searching for a Breakthrough with Cell & Gene Therapy Thursday, January 28, 2010
12/14/2009
The US Drug Watchdog Initiates a National Investigation of Gadolinium-Medical MRI`s- Kidney Disease and NSF
12/10/2009
Brain tumor radiation resistance defeated
12/06/2009
IBTA Newsletter
12/02/2009
Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial
Brain Tumor Cells Made More Responsive to Radiation
11/30/2009
Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer
Cytotoxic Effects of Temozolomide and Radiation are Additive- and Schedule-Dependent.
Added article about different way to start Temodar
Human cytomegalovirus UL76 induces chromosome aberrations.
Sagopilone, a microtubule stabilizer for the potential treatment of cancer.
Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis
11/22/2009
Montgomery couple remembers the daughter they lost to DIPG
20-25 Per Cent Of Brain Cancer Patients Show Verbal And Physical Aggression
11/21/2009
European advisory committee declines to recommend Avastin approval for deadly brain cancer
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.